TrialClinical trialPHN-02882026-10-21 19:00 CT
GLycaemic Outcomes With Whey Protein in ageING
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A recruiting study listed on ClinicalTrials.gov will evaluate whey protein’s effects on glucose control in adults aged 70–90 with type 2 diabetes. The placebo-controlled, partial crossover trial will assess glucose excursions over 7-day periods; the excerpt reports no results.
01—Key points
- 01The study focuses on glucose control under free-living conditions.
- 02Participants receive whey protein and a non-protein placebo in randomized order.
- 03No peptides from the provided list are mentioned.
Why it matters Editorial
The trial examines glucose control in older adults, but its relevance to peptide-based longevity is indirect.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.